Learning outcomes After discussing this case, students will be able to understand the challenges faced by social entrepreneurs in starting a health-tech start-up in Africa; create and evaluate lean business models of health-tech companies as a social enterprise; evaluate how health-tech start-ups were developing innovative business models and supply chain networks to make prescription drugs accessible and available in Africa; understand how inorganic growth strategies can help health-tech start-ups scale up; and evaluate what promises investors were seeing while investing in social enterprises in the health-care sector in Africa and what social wealth they were creating. Case overview/synopsis In August 2022, Gregory Rockson (Rockson), social entrepreneur and founder of for-profit health technology (health-tech) social enterprise in Ghana, mPharma, stated that he had plans to replicate the company’s business model, which provided people access to drugs and at affordable prices, to other African nations, beyond the company’s existing footprint. However, analysts pointed out that the fragmented drug supply chain and poor regulation in the health-care market across Africa could act as a challenge for mPharma to replicate its business model successfully across the African continent. People in Africa were forced to pay higher prices to buy life-saving drugs due to the continent’s fragmented drug supply chain. To add to their woes, pharmacies struggled to keep life-saving and life-sustaining medicines in stock. Often, patients traveled miles to a pharmacy only to find out that the drugs they needed were not in stock. In addition to this, the markets were flooded with counterfeit drugs. And the Covid-19 pandemic only exacerbated the situation. mPharma managed the prescription drug inventory for pharmacies and drug suppliers using its proprietary vendor management information system. By using the technology infrastructure it had built, the company connected patients, pharmacies and hospitals through a cloud-based software. The system enabled doctors to track in real-time which drugs were available and at which location, thus giving patients reliable access to medicines. Patients registering with mPharma with their prescriptions and medical history received an alert on their mobile phones notifying them where the drugs they needed were available. mPharma bought drugs from major drug manufacturers such as Novartis International AG, Pfizer Inc. (Pfizer) and Bayer AG, on behalf of the pharmacies. This enabled the pharmacies to save on the up-front costs of stocking the drugs, reduced supply constraints and ensured availability of drugs to consumers in these underserved markets. The company had a consignment model wherein member pharmacies had to pay only for what they sold. Most pharmacies forecast the number of drugs they needed and purchased them from mPharma at pre-agreed rates. The company took the inventory liability to prevent pharmacies from going out of stock. As mPharma used its purchasing power to buy drugs in large quantities from drug manufacturers and suppliers, it was able to help patients realize cost savings of 30% to 60% in the purchase of medicines. mPharma was focusing on achieving its ambitious goal of dominating the health-care market in Africa in future. However, analysts felt that the company would face challenges related to poor regulation in the health-care market, high prices of drugs and the fragmented pharmacy retail market in the continent. Complexity academic level This case is intended for use in MBA/MS level programs as part of a course on Social Entrepreneurship, Sustainability, Business Model Innovation, Disruptive Business Models, and Supply Chain Management in the Drug Industry. Supplementary materials Teaching notes are available for educators only. Subject code CSS 3: Entrepreneurship.

No abstract

No abstract

Study level/applicability MBA/MS level programs. Subject area Social entrepreneurship, sustainability and business strategy. Case overview The case discusses about how social entrepreneur Katerina Kimmorley founded Pollinate Energy with five of her friends to provide solar lights to the urban slum dwellers in Bengaluru, the capital city of Karnataka, a state in the Southern part of India. The company recruited people known as “Pollinators” for distributing their solar lights to the communities on installments making it affordable to them. To scale-up its sustainable energy initiatives and expand its global reach, Pollinate Energy merged with the US-based solar energy company Empower Generation in 2018 to form Pollinate Group. Since the company was making losses and was a nonprofit organization, the new CEO of Pollinate Group Sujatha Ramani and the senior management team had to tackle the challenge of scaling up the company while financially empowering women microentrepreneurs from marginalized communities. Expected learning outcomes Study Pollinate Energy’s business model and explore ways in which it can be made sustainable. Discuss the personality traits of Kimmorley which contributed to her success. Discuss how the merger with Empower Generation will help Pollinate Group in expanding its global reach. Explore ways in which the venture can be scaled up further. Social implications Pollinate Group focused on women empowerment to tackle the gender inequality challenge. The company provided equal opportunities for men and women, thereby removing discrimination from access to opportunities, sources, services and promotion of equal rights. Supplementary materials Teaching notes are available for educators only. Subject code CSS 3: Entrepreneurship

The banking and financial services industry is getting disintermediated. The platform model is disrupting almost every industry and banking and financial services industry is not an exception. Platform players are giving serious competition to the traditional banking and financial services players. The disintermediation of the vertically integrated value chain is altering the industry landscape across geographies. Amazon, Google, Apple, Facebook in North America and Alibaba, Baidu and Tencent in China are acquiring new customers and offering products and services on their ecosystem as Orchestrators, while their partners are taking advantage of the ecosystem and creating competitive advantage through their products and services. The disruption of the traditional vertically integrated industry structure looks real and may have reaching consequences. The cost advantage of the platform model will lure firms to be partners in this model. The network effect of the platform model makes it a sustainable business model with long term revenue opportunities. Traditional firms may need to alter the way they did business to survive the onslaught from platform players.